medigraphic.com
ISSN 2225-4676 (Electronic)

2022, Number 1

<< Back Next >>

Rev Cubana Neurol Neurocir 2022; 12 (1)

Surgical or conservative treatment and mortality in patients with deep spontaneous intracerebral hematoma

Sánchez PME, Paul FS, Goyenechea GFF, Zarrabeitia OLE

Language: Spanish
References: 38
Page: 1-22
PDF size: 395.34 Kb.


ABSTRACT

Introduction: Evacuation of spontaneous intracerebral hematoma is part of its treatment. Postoperative mortality is high in deep hematomas and sometimes higher than when conservative treatment is performed.
Objective: To compare the hospital mortality of patients with deep spontaneous intracerebral hematoma without hydrocephalus, in relation to surgical or conservative treatment.
Methods: This is an analytical study carried out at General Calixto García University Hospital, from January 2016 to December 2019, in patients diagnosed with deep spontaneous intracerebral hematoma without hydrocephalus, 32 operated by craniotomy and evacuation of the hematoma and 30 treated conservatively that resulted from random age matching, data were obtained from medical records. The t-student test, Fisher's exact statistic and odd ratio were used.
Results: Mortality was related to older age in both groups (p= 0.032 in the surgical group and p= 0.021 in the conservative group), as well as the Glasgow Coma Scale ≤ 8 points (p= 0.001 in the surgical group and p= 0.008 in the conservative group); mortality was 84.4% in the surgical procedure and 63.3% in the conservative procedure. This difference was significant (p= 0.045).
Conclusions: In patients with deep spontaneous intracerebral hematoma without hydrocephalus, higher mortality is associated with older age and values on the Glasgow scale for coma ≤ 8 points, both factors of poor prognosis. In turn, in those treated by craniotomy and evacuation of the hematoma, there are more deaths than in those treated conservatively.


REFERENCES

  1. Hemphill JC, Greenberg SM, Anderson CS, Becker K, Bendok BR, Broderick JP, et al.Guidelines for the Management of Spontaneous Intracerebral Hemorrhage. A Guideline forHealthcare Professionals from the American Heart Association/American Stroke Association.Stroke. 2015 [acceso 02/07/2021];46(9):2032–60. Disponible en:http://stroke.ahajournals.org/content/46/7/2032

  2. de Oliveira AL, Goffi A, Godinho F, Turkel-Parrella D, Duggal A, Marotta TR, et al.The criticalcare management of spontaneous intracranial hemorrhage: a contemporary review. Critic Care.2016;20:272–300. DOI:10.1186/s13054-016-1432-0

  3. Mendelow AD, Gregson BA, Rowan EN, Murray GD, Gholkar A, Mitchell PM;groupSTICHII Investigators. Early surgery versus initial conservative treatment in patients with spontaneous supratentorial lobar intracerebralhaematomas (STICH II): a randomised trial. Lancet.2013;382:397-408. DOI:10.1016/S0140-6736(13)60986-1

  4. Zheng J, Li H, Zhao HX, Guo R, Lin S, Dong W, et al.Surgery for patients with spontaneousdeep supratentorialintracerebral hemorrhage. A retrospective case-control study using propensityscore matching. Medicine. 2016;95(11):3024-31. DOI:10.1097/MD.0000000000003024

  5. 5.Menon G. Surgery for spontaneous intracerebral hemorrhage: Emerging trends. Arch MedHealth Sci. 2017;5:65 70. DOI:10.4103/amhs.amhs_42_17

  6. Sánchez ME. Factores pronósticos de mortalidad posoperatoria por hematoma intracerebralespontáneo. AHCG. 2019 [acceso 03/07/2021];7(3). Disponible en:http://www.revcalixto.sld.cu/index.php/ahcg/article/view/407

  7. Sánchez ME, Verdial R, Menéndez DM, Barbosa A, Manfugás G, Domínguez A. Protocolo deactuación médica para el tratamiento quirúrgico del hematoma intracerebral espontáneo. AHCG.2020 [acceso 03/07/2021];8(1). Disponible en:http://www.revcalixto.sld.cu/index.php/ahcg/article/view/457/411

  8. Mendelow AD, Gregson BA, Mitchell PM, Murray GD, Rowan EN, Gholkar AR; group STICHII Investigators. Surgical Trial in Lobar Intracerebral Haemorrhage (STICH II) protocol. Trials.2011;12:124-30. DOI:10.1186/1745-6215-12-124

  9. Webb AJS, Ullman NL, Morgan TC.Accuracy of the ABC/2 score for intracerebral hemorrhage:systematic review and analysis of MISTIE, CLEAR-IVH, and CLEAR III. Stroke.2015;46(9):2470-6. DOI:10.1161/STROKEAHA.114.007343

  10. Daniel WW. Bioestadística. Base para el análisis de las ciencias de la salud. 2da ed. México,D. F.: Limusa; 1991 [acceso 04/07/2021]. Disponible en: http://www.academia.edu/42694701

  11. Raj R, Bendel S, Reinikainen M, Hoppu S, Laitio R, Ala-Kokko T, et al. Costs, outcome andcost-effectiveness of neurocritical care: a multi-center observational study. Critic Care.2018;22:225-31. DOI:10-1186/s13054-018-2151-5

  12. Specogna AV, Patten SB, Turin TC, Hill MD. Hospital treatment costs and length of stayassociated with hypertension and multimorbidity after hemorrhagic stroke. BMC Neurol.2017;17:158-66. DOI: https://dx.doi.org/10-1186/s12883-017-0930-2

  13. Suárez A, Álvarez A, López E, Bárzaga S, Santisteban A. Pronóstico de muerte en pacientescon hemorragia intracerebral supratentorial espontánea. Rev Finlay. 2016 [acceso 05/07/2021];6(1):32-40. Disponible en:http://www.revfinlay.sld.cu/index.php/finlay/article/view/408

  14. Aguilera OR, González D. Factores pronósticos en la hemorragia cerebralintraparenquimatosa. Medisan (Santiago de Cuba). 2012 [acceso 05/07/2021];16(1):21-8.Disponible en: http://scielo.sld.cu/pdf/san/v16n1/san03112.pdf

  15. Rodríguez LA. Indicadores morfométricos predictores de mortalidad en pacientes conhemorragias intracerebrales lobares espontaneas. Mediciego. 2016 [acceso 05/07/2021];22(3):37-42. Disponible en: http://www.revmediciego.sld.cu/index.php/mediciego/article/view/512/1010

  16. Pérez AR, García A, Sosa EF, Padrón F. Factores pronósticos de mortalidad por hemorragiaintracerebral en el periodo agudo. Rev Cubana Med Milit. 2015 [acceso 05/07/2021];44(3):277-88. Disponible en: https://www.medigraphic.com/cgibin/new/resumen.cgi/IDARTICULO=64146

  17. Lacerda AJ, Hernández O, Díaz JA, Pérez S, Mazorra M, Abreu D. Tratamiento quirúrgico enlas hemorragias intracerebrales lobares espontáneas supratentoriales sin extensión ventricular. RevChilena Neurocir. 2015 [acceso: 05/07/2021];41:45-53. Disponible en:https://www.hindawi.com/journals/bmri/2014/898762/

  18. Lacerda AJ, Díaz JA, Martín JC, Pérez S, Martín D, Abreu D. Resultados de 11 años detratamiento quirúrgico en las hemorragias intracerebrales lobares espontáneas supratentoriales.Rev Cubana Neurol Neurocir. 2012 [acceso 05/07/2021];2(2):114-20. Disponible en:http://www.revneuro.sld.cu/index.php/neu/article/view/44

  19. Kurian C, Kaur K, Kaur G, Sahni R. Assessment of the patient with intracerebral hemorrhage:a review of the literature. Cardiol Rev. 2021;29(1):20-5. DOI:10.1097/CRD.0000000000000332

  20. Hemphill JC, Bonovich DC, Besmertis L, Manley GT, Johnston SC. The ICH Score. A simple,reliable Grading Scale for Intracerebral Hemorrhage. Stroke. 2001 [acceso 02/072021];32:891-7.Disponible en: http://www.stroke.ahajournals.org/content/32/4/891

  21. Safatli DA, Gunther A, Schlattmann P, Schwarz F, Kalff R, Ewald C. Predictors of 30-daymortality in patients with spontaneous primary intracerebral hemorrhage. Surg Neurol Int.2016;7(Suppl 18):S510-7. DOI:10.4103/2152-7806.187493

  22. Gregson BA, Broderick JP, Auer LM, Batjer H, Chen XC, Juvela S, et al. Individual patientdata subgroup meta-analysis of surgery for spontaneous supratentorial intracerebral hemorrhage.Stroke. 2012;431496–1504. DOI:10.1161/STROKEAHA.111.640284

  23. Prasad K, Mendelow AD, Gregson B. Surgery for primary supratentorial intracerebralhaemorrhage. Cochrane Database Syst Rev. 2008;(4):CD000200.DOI:10.1002/14651858.CD000200.pub2

  24. Fahlström A, Nittby H, Zeberg H, Bartek J Jr, Bartley A, Tobieson L. A grading scale forsurgically treated patients with spontaneous supratentorial intracerebral hemorrhage: the Surgicalwedish ICH Score. J Neurosurg. 2019;133(3):1-8. DOI:10.3171/2019.5.JNS19622

  25. Mukherjee SK, Quddus R, Farazi MA, Islam MN. The GVS: Glasgow Coma Score, Volume& site of Hemorrhage as a Simple Scoring System for Intracerebral hemorrhage. SOJ Neurol.2016;3(1):1-5. DOI:10.15226/2374-6858/3/1/00124

  26. Orito K, Hirohata M, Nakamura Y. Leakage sign for primary intracerebral hemorrhage: a novelpredictor of hematoma growth. Stroke. 2016;47:958-63. DOI:10.1161/STROKEAHA.115.011578

  27. Gregorio T, Pipa S, Cavaleiro P, Atanasio G, Albuquerque I, Castro P, et al. Assessment andcomparison of the Four Most Extensively Validated Prognostic Scales for IntracerebralHemorrhage: systematic Review with Meta-analysis. Neurocrit Care. 2019;(2):449-66.DOI:10.1007/s12028-018-0633-6

  28. Kim JY, Bae HJ. Spontaneous Intracerebral Hemorrhage: Management. J Stroke.2017;19(1):28-39. DOI: 10.5853/jos.2016.01935

  29. Rivera R, Guerrero F, Rodríguez D, Gómez FJ, Rodríguez F, Mora J, et al. Survival analysisof surgically evacuated supratentorial spontaneous intracerebral hemorrhage with intraventricularextension. Neurocirugia (Astur). 2016;27(5):220-8. DOI:10.1016/j.neurocir.2016.01.003

  30. Rodríguez D. Evaluación de la intervención quirúrgica en pacientes con hemorragiaintracerebral espontánea supratentorial con extensión intraventricular [tesis]. Universidad deGranada: Facultad de Medicina; 2016 [acceso 06/07/2021]. Disponible en:http://www.hdl.handle.net/10481/43633

  31. Dey M, Stadnik A, AwadI A. Spontaneous intracerebral and intraventricular hemorrhage:advances in minimally invasive surgery and thrombolytic evacuation, and lessons learned in recenttrials. Neurosurgery. 2014;74(Suppl 1):S142–50. DOI:10.1227/NEU.0000000000000221

  32. Zheng J, Li H, Guo R, Lin S, Hu X, Dong W, et al. Minimally invasive surgery treatment forthe patients with spontaneous supratentorial intracerebral hemorrhage (MISTICH): protocol of amulti-center randomized controlled trial. BMC Neurol. 2014 [acceso 06/07/2021];14:06-11.Disponible en: http://www.biomedcentral.com/1471-2377/14/206

  33. Zhang HZ, Li YP, Yan ZC, Wang XD, She L, Dong L. Endoscopic evacuation of basal gangliahemorrhage via keyhole approach using an adjustable cannula in comparison with craniotomy. BioMed Res Internat. 2014;89(8). DOI: 10.11155/2014/898762

  34. Zhou X, Chen J, Li Q, Ren G, Yao G, Liu M, et al. Minimally invasive surgery for spontaneoussupratentorial intracerebral hemorrhage: a meta-analysis of randomized controlled trials. Stroke.2012 [acceso 06/07/2021];43:2923-30. Disponible en: http://www.biomedcentral.com/1471-2377/14/206

  35. Zyck S, Du L, Gould G, Latorre JG, Beutler T, Bodman A. Scoping review and commentaryon prognostication for patients with intracerebral hemorrhage with advances in surgicaltechniques. Eurocrit Care. 2020;33(1):256-72. DOI: 10.1007/s12028-020-0962-y

  36. Pantazis G, Tsitsopoulos P, Mihas C. Early surgical treatment vs conservative management forspontaneous supratentorial intracerebral hematomas: a prospective randomized study. SurgNeurol. 2006;66(5):492-501. DOI: 16/j.surneu.2006.05.054

  37. Mould WA, Carhuapoma JR, Muschelli J, Lane K, Morgan TC, McBee NA; group MISTIEInvestigators. Minimally invasive surgery plus recombinant tissue-type plasminogen activator forintracerebral hemorrhage evacuation decreases perihematomal edema (MISTIE II). Stroke.2013;44:627-34. DOI:10.1161/STROKEAHA.111.000411

  38. Hanley DF, Thompson RE, Rosenblum M. Efficacy and safety of minimally invasive surgerywith thrombolysis in intracerebral haemorrhage evacuation (MISTIE III): a randomized,controlled, open-label, blinded endpoint phase 3 trial. Lancet. 2019;93(10175):1021-32.DOI:10.1016/S0140-6736(19)30195-3




2020     |     www.medigraphic.com